Richard E. Kaufman
Keine laufenden Positionen mehr
Profil
Richard E.
Kaufman worked as a Director of Research & Development at Guidant Vascular Intervention and as a VP & GM of Bioabsorbable Vascular Solutions at Abbott Laboratories.
He then worked at Intersect ENT, Inc. for 11 years as COO and Senior VP of Research & Development.
Prior to that, he was a Principal at McGhan Medical SARL.
Kaufman received his undergraduate degree from Arizona State University.
Ehemalige bekannte Positionen von Richard E. Kaufman
| Unternehmen | Position | Ende |
|---|---|---|
| INTERSECT ENT, INC. | Geschäftsführer | 29.10.2018 |
| McGhan Medical SARL | Corporate Officer/Principal | - |
| Guidant Vascular Intervention | Technik-/Wissenschafts-/F&E-Leiter | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ausbildung von Richard E. Kaufman
| Arizona State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
| Guidant Vascular Intervention | |
| McGhan Medical SARL | Distribution Services |
